Skip to main content
Top
Published in: Journal of Cancer Education 6/2021

01-12-2021 | Human Papillomavirus

Using Key Informants to Evaluate Barriers to Education and Acceptability of the HPV Vaccine in Tanzania: Implications for Cancer Education

Authors: Daina C. Keehn, Robert M. Chamberlain, Melissa Tibbits, Crispin Kahesa, Khadija Msami, Amr S. Soliman

Published in: Journal of Cancer Education | Issue 6/2021

Login to get access

Abstract

Cervical cancer is the third most common cancer globally, with high mortality when left untreated. In sub-Saharan Africa, Tanzania shows higher incidence rates of cervical cancer at 59.1 per 100,000 compared with the global average of 13.1 per 100,000. The HPV vaccine has been shown to successfully reduce HPV infection and is recommended for school-age girls and boys in the USA. Understanding the acceptability of the HPV vaccine and the barriers to vaccination is important for ensuring that HPV vaccination programs are successful. In 2016, Tanzania began school-based HPV vaccination programs in cities and towns surrounding Dar es Salaam, the largest city in Tanzania. Successful implementation of HPV vaccination programs in Dar es Salaam relies on overcoming barriers to vaccination. This study focused on primary school teachers as key informants to assess these barriers. Participants were given a short survey and then asked to participate in focus group sessions. Overall, knowledge of HPV was low, with only 37% of participants having heard of the HPV and only 28.6% having heard of the HPV vaccine. Teachers had a very positive response to the HPV educational sessions. Of the teachers who completed the questionnaires, 100% of them were willing to speak with their school parents about the HPV vaccine and 99% would recommend this vaccine to parents. This study has significant implications for national cancer prevention vaccination programs, not only in Tanzania, but also in other countries starting HPV vaccination as teachers are potentially important advocates for immunization and other childhood health initiatives.
Literature
1.
go back to reference Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M (GCO) et al. . 2018. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer. https://gco.iarc.fr/today. Accessed 14 March 2020 Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M (GCO) et al. . 2018. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer. https://​gco.​iarc.​fr/​today. Accessed 14 March 2020
4.
go back to reference Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J (ICO/IARC) et al. . 2019. Information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in Tanzania. Summary Report 17 June 2019. Accessed 14 March 2020 Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J (ICO/IARC) et al. . 2019. Information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in Tanzania. Summary Report 17 June 2019. Accessed 14 March 2020
6.
go back to reference Muñoz N, Bosch, F. X., De Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348(6), 518–527 Muñoz N, Bosch, F. X., De Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348(6), 518–527
8.
go back to reference World Population Review (WPR). 2015. World population review: Tanzania population 2015. http://worldpopulationreviewcom/countries/tanzania-population/ Accessed 21 November 2015 World Population Review (WPR). 2015. World population review: Tanzania population 2015. http://worldpopulationreviewcom/countries/tanzania-population/ Accessed 21 November 2015
9.
go back to reference PATH Program for Appropriate Technology in Health (2011) Implementing HPV vaccination programs: practical experience from path. RHO, Seattle, WA PATH Program for Appropriate Technology in Health (2011) Implementing HPV vaccination programs: practical experience from path. RHO, Seattle, WA
10.
go back to reference Campos NG, Kim JJ, Castle PE, Ortendahl JD, O’Shea M, Diaz M, Goldie SJ (2012) Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in eastern Africa. Int J Cancer 130(11):2672–2684CrossRef Campos NG, Kim JJ, Castle PE, Ortendahl JD, O’Shea M, Diaz M, Goldie SJ (2012) Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in eastern Africa. Int J Cancer 130(11):2672–2684CrossRef
11.
go back to reference Gavi (Vaccine Alliance). 2015. Every child counts: the vaccine alliance progress report 2014 Gavi (Vaccine Alliance). 2015. Every child counts: the vaccine alliance progress report 2014
12.
go back to reference Ladner J, Besson M, Rodrigues M, Audureau E, Saba J (2014) Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013. BMC Public Health 14(1):1CrossRef Ladner J, Besson M, Rodrigues M, Audureau E, Saba J (2014) Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013. BMC Public Health 14(1):1CrossRef
13.
go back to reference Watson-Jones D, Tomlin K, Remes P, Baisley K, Ponsiano R, Soteli S, de Sanjosé S, Changalucha J, Kapiga S, Hayes RJ (2012) Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS One 7(10):e45231CrossRef Watson-Jones D, Tomlin K, Remes P, Baisley K, Ponsiano R, Soteli S, de Sanjosé S, Changalucha J, Kapiga S, Hayes RJ (2012) Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS One 7(10):e45231CrossRef
14.
go back to reference Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, Kapiga S, Mayaud P, de Sanjose S, Wight D, Changalucha J, Hayes R (2012) Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis 206(5):678–686CrossRef Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, Kapiga S, Mayaud P, de Sanjose S, Wight D, Changalucha J, Hayes R (2012) Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis 206(5):678–686CrossRef
15.
go back to reference Remes P., Selestine,V., Changalucha, J., Ross, D. A., Wight, D., de Sanjosé, S., et al. 2012. A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in Northwest Tanzania. Vaccine, 30(36), 5363–5367 Remes P., Selestine,V., Changalucha, J., Ross, D. A., Wight, D., de Sanjosé, S., et al. 2012. A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in Northwest Tanzania. Vaccine, 30(36), 5363–5367
16.
go back to reference Carlsen B, Glenton C (2011) What about N? A methodological study of sample-size reporting in focus group studies. BMC Med Res Methodol 11(1):1CrossRef Carlsen B, Glenton C (2011) What about N? A methodological study of sample-size reporting in focus group studies. BMC Med Res Methodol 11(1):1CrossRef
Metadata
Title
Using Key Informants to Evaluate Barriers to Education and Acceptability of the HPV Vaccine in Tanzania: Implications for Cancer Education
Authors
Daina C. Keehn
Robert M. Chamberlain
Melissa Tibbits
Crispin Kahesa
Khadija Msami
Amr S. Soliman
Publication date
01-12-2021
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 6/2021
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01773-7

Other articles of this Issue 6/2021

Journal of Cancer Education 6/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine